600216 浙江医药
已收盘 09-11 15:00:00
资讯
新帖
简况
每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会
证券之星 · 09-13 01:49
每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会
浙江医药新提交“RUUF MEEW”商标注册申请
证券之星 · 09-12 07:27
浙江医药新提交“RUUF MEEW”商标注册申请
浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%
证券之星 · 09-08
浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%
每周股票复盘：浙江医药（600216）回购进展显示已购903,100股
证券之星 · 09-06
每周股票复盘：浙江医药（600216）回购进展显示已购903,100股
浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%
证券之星 · 09-01
浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%
每周股票复盘：浙江医药（600216）Q2净利增20.73%
证券之星 · 08-30
每周股票复盘：浙江医药（600216）Q2净利增20.73%
浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-27
浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显
图解浙江医药中报：第二季度单季净利润同比增长20.73%
证券之星 · 08-26
图解浙江医药中报：第二季度单季净利润同比增长20.73%
8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股
证券之星 · 08-24
8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股
8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股
证券之星 · 08-21
8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股
异动快报：浙江医药（600216）8月12日10点25分触及涨停板
证券之星 · 08-12
异动快报：浙江医药（600216）8月12日10点25分触及涨停板
每周股票复盘：浙江医药（600216）拟回购1-2亿元股份
证券之星 · 07-26
每周股票复盘：浙江医药（600216）拟回购1-2亿元股份
浙江医药（600216）披露以集中竞价交易方式回购股份的回购报告书，7月20日股价上涨1.9%
证券之星 · 07-20
浙江医药（600216）披露以集中竞价交易方式回购股份的回购报告书，7月20日股价上涨1.9%
每周股票复盘：浙江医药（600216）拟回购1至2亿元股份
证券之星 · 07-19
每周股票复盘：浙江医药（600216）拟回购1至2亿元股份
浙江医药（600216）披露回购股份事项前十大股东持股情况，7月17日股价下跌3.97%
证券之星 · 07-17
浙江医药（600216）披露回购股份事项前十大股东持股情况，7月17日股价下跌3.97%
浙江医药（600216）披露以集中竞价交易方式回购股份方案，7月14日股价上涨2.35%
证券之星 · 07-14
浙江医药（600216）披露以集中竞价交易方式回购股份方案，7月14日股价上涨2.35%
每周股票复盘：浙江医药（600216）国投高科减持计划届满未减持
证券之星 · 07-12
每周股票复盘：浙江医药（600216）国投高科减持计划届满未减持
浙江医药（600216）披露持股5%以上股东减持计划届满暨未减持股份公告，7月7日股价下跌5.84%
证券之星 · 07-07
浙江医药（600216）披露持股5%以上股东减持计划届满暨未减持股份公告，7月7日股价下跌5.84%
7月7日浙江医药跌5.84%，天弘医疗健康混合A基金重仓该股
证券之星 · 07-07
7月7日浙江医药跌5.84%，天弘医疗健康混合A基金重仓该股
每周股票复盘：浙江医药（600216）新码生物递表港交所拟上市
证券之星 · 07-05
每周股票复盘：浙江医药（600216）新码生物递表港交所拟上市
加载更多
公司概况
公司名称：
浙江医药股份有限公司
所属行业：
医药制造业
上市日期：
1999-10-21
主营业务：
浙江医药股份有限公司的主营业务是药品与生命营养品的研发、生产和销售以及药品流通。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素、医药制造类产品、医药商业。公司在第二十四届世界制药原料中国展（CPHIChina2026）荣获可持续影响力奖“ESG责任企业奖”。
发行价格：
5.16
{"stockData":{"symbol":"600216","market":"SH","secType":"STK","nameCN":"浙江医药","latestPrice":12.33,"timestamp":1789110000000,"preClose":12.55,"halted":0,"volume":16813305,"delay":0,"changeRate":-0.0175,"floatShares":951000000,"shares":961999999,"eps":0.8383,"marketStatus":"已收盘","change":-0.22,"latestTime":"09-11 15:00:00","open":12.44,"high":12.6,"low":12.15,"amount":207000000,"amplitude":0.0359,"askPrice":12.34,"askSize":53,"bidPrice":12.33,"bidSize":294,"shortable":0,"etf":0,"ttmEps":0.8383,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.55,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":13.81,"lowLimit":11.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":961637750,"isCdr":false,"pbRate":1.02,"roa":"--","peRate":14.708338,"roe":"5.37%","epsLYR":0.91,"committee":0.658407,"marketValue":11857000000,"turnoverRate":0.0177,"status":1,"floatMarketCap":11731000000},"requestUrl":"/m/hq/s/600216","defaultTab":"news","newsList":[{"id":"2667950737","title":"每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667950737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667950737?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:49","pubTimestamp":1789235351,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，浙江医药报收于12.33元，较上周的12.68元下跌2.76%。本周，浙江医药9月9日盘中最高价报13.04元。本周关注点公司公告汇总：浙江医药将于2026年9月15日召开半年度业绩说明会。公司公告汇总浙江医药关于召开2026年半年度业绩说明会的公告浙江医药股份有限公司将于2026年9月15日10:00-11:00通过上证路演中心以视频直播和网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果和财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0188","BK0239","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666904577","title":"浙江医药新提交“RUUF MEEW”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666904577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666904577?lang=zh_cn&edition=full","pubTime":"2026-09-12 07:27","pubTimestamp":1789169236,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日浙江医药股份有限公司新提交“RUUF MEEW”商标注册申请。商标申请详情如下：今年以来浙江医药股份有限公司新申请注册商标26件，截止目前公司共持有注册商标370件，另有28件商标尚在注册申请中。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了2.46亿元，同比减21.39%。通过天眼查大数据分析，浙江医药股份有限公司共对外投资了36家企业，参与招投标项目100次；财产线索方面有商标信息225条，专利信息27条，著作权信息4条；此外企业还拥有行政许可116个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200006588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0188","BK0239","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321103","title":"浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321103?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:05","pubTimestamp":1788861934,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，浙江医药报收于12.95元，较前一交易日上涨1.41%，最新总市值为124.53亿元。该股当日开盘12.72元，最高12.98元，最低12.7元，成交额达2.02亿元，换手率为1.66%。浙江医药当日发布公告称，公司将于2026年9月15日10:00-11:00通过上证路演中心以视频直播和网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果和财务状况。投资者可于2026年9月8日至9月14日16:00前通过上证路演中心网站或公司邮箱board@zmc-china.com提问。说明会后可通过该平台查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0191","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365730","title":"每周股票复盘：浙江医药（600216）回购进展显示已购903,100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365730","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365730?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:30","pubTimestamp":1788633031,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，浙江医药报收于12.68元，较上周的13.19元下跌3.87%。本周，浙江医药8月31日盘中最高价报13.09元。浙江医药当前最新总市值121.94亿元，在化学制药板块市值排名36/149，在两市A股市值排名1515/5214。本周关注点公司公告汇总：回购进展显示已购903,100股，支付金额11,536,865.00元公司公告汇总浙江医药关于股份回购进展公告：截至2026年8月31日，公司累计回购股份903,100股，占总股本的0.09%，已支付金额11,536,865.00元，回购价格区间为12.55元/股至13.00元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","BK0188","600216","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664411837","title":"浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664411837","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664411837?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:31","pubTimestamp":1788255111,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，浙江医药报收于12.88元，较前一交易日下跌0.39%，最新总市值为123.86亿元。公司于近日披露《浙江医药关于股份回购进展公告》。公告显示，浙江医药股份有限公司于2026年7月14日召开董事会，审议通过以集中竞价交易方式回购股份的议案，回购资金总额为1亿元至2亿元，回购价格不超过17.90元/股，回购期限为2026年7月14日至2027年7月13日，回购股份拟用于员工持股计划或股权激励。本次回购符合相关法规及公司回购方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100030611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0188","BK0239","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010969","title":"每周股票复盘：浙江医药（600216）Q2净利增20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010969","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010969?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:47","pubTimestamp":1788029229,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，浙江医药报收于13.19元，较上周的13.23元下跌0.3%。本周，浙江医药8月26日盘中最高价报13.35元。本周关注点来自业绩披露要点：2026年第二季度归母净利润同比上升20.73%。来自股本股东变化：截至2026年6月30日股东户数为5.56万户，较上期增加7.26%。户均持股数量由1.86万股下降至1.73万股，户均持股市值为19.72万元。第二季度单季主营收入21.95亿元，同比上升6.18%；单季度归母净利润3.19亿元，同比上升20.73%；单季度扣非净利润2.91亿元，同比上升10.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0191","BK0028","600216","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740303","title":"浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740303?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:03","pubTimestamp":1787781802,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期浙江医药发布2026年中报。截至本报告期末，公司营业总收入43.86亿元，同比上升1.46%，归母净利润6.06亿元，同比下降9.99%。本报告期浙江医药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达36.54%。持有浙江医药最多的基金为天弘医疗健康混合A，目前规模为2.15亿元，最新净值1.8044，较上一交易日上涨0.29%，近一年下跌6.15%。本文数据来源于浙江医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600216","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751341","title":"图解浙江医药中报：第二季度单季净利润同比增长20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751341","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662751341?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:20","pubTimestamp":1787682035,"startTime":"0","endTime":"0","summary":"证券之星消息，浙江医药2026年中报显示，上半年度公司主营收入43.86亿元，同比上升1.46%；归母净利润6.06亿元，同比下降9.99%；扣非净利润5.65亿元，同比下降15.05%；其中2026年第二季度，公司单季度主营收入21.95亿元，同比上升6.18%；单季度归母净利润3.19亿元，同比上升20.73%；单季度扣非净利润2.91亿元，同比上升10.68%；负债率18.48%，投资收益2947.95万元，财务费用6878.6万元，毛利率37.15%。财报数据概要请见下图:本文数据来源于浙江医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661138221","title":"8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661138221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661138221?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:27","pubTimestamp":1787560031,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日浙江医药跌5.14%，收盘报12.55元，换手率4.12%，成交量39.23万手，成交额5.01亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.15亿元，最新净值1.8229，较上一交易日下跌3.09%，近一年下跌6.15%。天弘医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0028","BK0188","BK0239","159760","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661655682","title":"8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661655682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661655682?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:38","pubTimestamp":1787301510,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日浙江医药跌8.88%，收盘报13.23元，换手率6.52%，成交量62.0万手，成交额8.38亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.15亿元，最新净值1.881，较上一交易日上涨1.84%，近一年下跌6.15%。天弘医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0191","BK0028","600216","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658401709","title":"异动快报：浙江医药（600216）8月12日10点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658401709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658401709?lang=zh_cn&edition=full","pubTime":"2026-08-12 10:30","pubTimestamp":1786501847,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息，10点25分浙江医药（600216）触及涨停板。其所属行业化学制药目前上涨。领涨股为美诺华。该股为维生素，钠电池，化学原料药概念热股，当日维生素概念上涨1.54%，钠电池概念上涨1.18%，化学原料药概念上涨0.54%。8月11日的资金流向数据方面，主力资金净流入729.26万元，占总成交额2.51%，游资资金净流出920.48万元，占总成交额3.17%，散户资金净流入191.22万元，占总成交额0.66%。近5日资金流向一览见下表：浙江医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200012346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0191","BK0188","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052252","title":"每周股票复盘：浙江医药（600216）拟回购1-2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052252?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:47","pubTimestamp":1785001632,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，浙江医药报收于11.63元，较上周的12.09元下跌3.8%。本周，浙江医药7月21日盘中最高价报12.44元。公司公告汇总浙江医药发布以集中竞价交易方式回购股份的报告书，拟回购资金总额不低于1亿元且不超过2亿元，资金来源于自有资金或自筹资金。公司已获得工商银行不超过1.8亿元的股票回购专项贷款承诺。回购股份将用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600216","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652717291","title":"浙江医药（600216）披露以集中竞价交易方式回购股份的回购报告书，7月20日股价上涨1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652717291","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652717291?lang=zh_cn&edition=full","pubTime":"2026-07-20 17:40","pubTimestamp":1784540418,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，浙江医药报收于12.32元，较前一交易日上涨1.9%，最新总市值为118.47亿元。近日，浙江医药发布《关于以集中竞价交易方式回购股份的回购报告书》。公告显示，公司拟以集中竞价交易方式回购股份，资金总额不低于1亿元且不超过2亿元，资金来源为自有资金或自筹资金，其中已获工商银行不超过1.8亿元的股票回购专项贷款承诺。回购股份价格不超过17.90元/股，回购期限为董事会审议通过之日起不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000027175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0191","BK0239","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423726","title":"每周股票复盘：浙江医药（600216）拟回购1至2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423726","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652423726?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:48","pubTimestamp":1784396893,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，浙江医药报收于12.09元，较上周的11.83元上涨2.2%。本周，浙江医药7月16日盘中最高价报12.74元。本周关注点公司公告汇总：浙江医药拟使用1亿元至2亿元回购股份，用于员工持股或股权激励。公司公告汇总浙江医药于2026年7月14日召开第十届十三次董事会会议，审议通过《关于以集中竞价交易方式回购股份的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","BK0188","600216","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289807","title":"浙江医药（600216）披露回购股份事项前十大股东持股情况，7月17日股价下跌3.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652289807?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:16","pubTimestamp":1784297775,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，浙江医药报收于12.09元，较前一交易日下跌3.97%，最新总市值为116.26亿元。该股当日开盘12.5元，最高12.64元，最低12.09元，成交额达3.12亿元，换手率为2.67%。近日，浙江医药发布《关于回购股份事项前十大股东和前十大无限售条件股东持股情况的公告》。前十大股东中，新昌县昌欣投资发展有限公司持股208,192,361股，占比21.65%；国投高科技投资有限公司持股150,127,573股，占比15.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0028","BK0188","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104650","title":"浙江医药（600216）披露以集中竞价交易方式回购股份方案，7月14日股价上涨2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104650","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104650?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:23","pubTimestamp":1784038992,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，浙江医药报收于12.17元，较前一交易日上涨2.35%，最新总市值为117.03亿元。近日，浙江医药发布《关于以集中竞价交易方式回购股份方案的公告》。公告显示，公司拟以集中竞价交易方式回购股份，回购金额不低于1亿元且不超过2亿元，资金来源为自有资金或自筹资金，其中包括工商银行提供的不超过1.8亿元专项贷款。回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0188","BK0028","600216","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154891","title":"每周股票复盘：浙江医药（600216）国投高科减持计划届满未减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154891?lang=zh_cn&edition=full","pubTime":"2026-07-12 01:57","pubTimestamp":1783792628,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，浙江医药报收于11.83元，较上周的12.29元下跌3.74%。本周，浙江医药7月6日盘中最高价报12.95元。公司于2026年3月17日披露，国投高科拟通过集中竞价交易方式减持不超过9,616,377股，即不超过公司总股本的1%。减持期间为2026年4月8日至2026年7月7日。截至2026年7月7日，国投高科未实施减持，减持计划时间届满，持股数量和比例不变，仍为150,127,573股，占总股本的15.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","600216","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649793694","title":"浙江医药（600216）披露持股5%以上股东减持计划届满暨未减持股份公告，7月7日股价下跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649793694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649793694?lang=zh_cn&edition=full","pubTime":"2026-07-07 23:04","pubTimestamp":1783436656,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘，浙江医药报收于12.1元，较前一交易日下跌5.84%，最新总市值为116.36亿元。近日，浙江医药发布《持股5%以上股东减持计划届满暨未减持股份的公告》。公司于2026年3月17日披露，国投高科拟通过集中竞价交易方式减持不超过9,616,377股，即不超过公司总股本的1%。减持期间为2026年4月8日至2026年7月7日。截至2026年7月7日，国投高科未实施减持，减持计划时间届满，持股数量和比例不变，仍为150,127,573股，占总股本的15.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700042325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0191","BK0239","BK0188","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649001686","title":"7月7日浙江医药跌5.84%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649001686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649001686?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:20","pubTimestamp":1783412407,"startTime":"0","endTime":"0","summary":"证券之星消息，7月7日浙江医药跌5.84%，收盘报12.1元，换手率3.33%，成交量31.68万手，成交额3.9亿元。重仓浙江医药的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700026715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600216","BK0188","159760","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694579","title":"每周股票复盘：浙江医药（600216）新码生物递表港交所拟上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694579","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649694579?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:00","pubTimestamp":1783188044,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，浙江医药报收于12.29元，较上周的11.29元上涨8.86%。本周，浙江医药7月3日盘中最高价报12.32元。公司公告汇总浙江医药拟分拆子公司新码生物至香港联交所主板上市。2026年6月29日，新码生物已通过保密形式向香港联交所递交H股发行上市申请文件。浙江医药因公司回购专用证券账户持有3,479,200股不参与利润分配，2025年度利润分配实施差异化分红。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0188","BK0191","BK0239","BK0028","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789333411437,"stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":-0.1046},{"period":"3month","weight":0.0511},{"period":"6month","weight":-0.2892},{"period":"1year","weight":-0.1728},{"period":"ytd","weight":-0.0892}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"55588人(较上一季度增加7.26%)","perCapita":"17115股","listingDate":"1999-10-21","address":"浙江省绍兴市越城区滨海新城致远中大道168号","registeredCapital":"96163万元","survey":" 浙江医药股份有限公司的主营业务是药品与生命营养品的研发、生产和销售以及药品流通。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素、医药制造类产品、医药商业。公司在第二十四届世界制药原料中国展（CPHIChina2026）荣获可持续影响力奖“ESG责任企业奖”。","listedPrice":5.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浙江医药,600216,浙江医药股票,浙江医药股票老虎,浙江医药股票老虎国际,浙江医药行情,浙江医药股票行情,浙江医药股价,浙江医药股市,浙江医药股票价格,浙江医药股票交易,浙江医药股票购买,浙江医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}